PeakShares »

Vertex Pharmaceuticals Incorporated shares owned by PeakShares

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by PeakShares from 13F filings

Historical chart of PeakShares investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by PeakShares consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by PeakShares

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.0M 2.2k 453.36

More positions owned by PeakShares

Vanguard Information Technology ETF Exchange-traded Funds (VGT)
State Street Technology Select Sector SPDR ETF USD Class Exchange-traded Funds (XLK)
State Street Financial Select Sector SPDR ETF USD Class Exchange-traded Funds (XLF)
State Street Health Care Select Sector SPDR ETF USD Class Exchange-traded Funds (XLV)
State Street Communication Services Select Sector SPDR ETF Exchange-traded Funds (XLC)
State Street Consumer Staples Select Sector SPDR ETF Exchange-traded Funds (XLP)
State Street Industrial Select Sector SPDR ETF USD Class Exchange-traded Funds (XLI)
Meta Platforms Common Stocks (META)
State Street Consumer Discretionary Select Sector SPDR ETF Exchange-traded Funds (XLY)
NVIDIA Corporation Common Stocks (NVDA)
Alphabet Common Stocks (GOOG)
Advanced Micro Devices Common Stocks (AMD)
State Street Utilities Select Sector SPDR ETF USD Class Exchange-traded Funds (XLU)
Salesforce Common Stocks (CRM)
Microsoft Corporation Common Stocks (MSFT)

View all positions for PeakShares

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Victory Capital Management
FMR
Jennison Associates
Norges Bank Investment Management

View all funds holding Vertex Pharmaceuticals Incorporated